<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Universitat de Barcelona</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Barcelona, Catalonia, Spain</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Public university</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1450</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.ub.edu/" target="_blank">Universitat de Barcelona official site</a></td>
</tr>
<tr>
<td class="label">Neurodegeneration Focus</td>
<td>Alzheimer's Disease, Parkinson's Disease, Neuroscience, Aging</td>
</tr>
<tr>
<td class="label">Major Units</td>
<td>Faculty of Biology, Faculty of Medicine, Institute of Neuroscience</td>
</tr>
</table>
Universitat de Barcelona
Overview
Mermaid diagram (expand to render)
Universitat De Barcelona plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
The Universitat de Barcelona (UB) is Spain's oldest and largest university, founded in 1450. Located in Barcelona, Catalonia, the university is a major center for neuroscience and neurodegenerative disease research in Europe. With over 100,000 students, UB combines excellence in basic science with strong clinical research programs in neurological diseases [1].
History
The Universitat de Barcelona has been a center of scientific excellence since its founding in 1450. The university's medical and biology faculties have developed renowned research programs in neuroscience over the past several decades, establishing UB as a leading institution for neurodegenerative disease research in Spain and Europe.
Academic Structure
Faculty of Biology
The Faculty of Biology conducts fundamental research in:
- Molecular mechanisms of neurodegeneration
- Protein aggregation and clearance pathways
- Cell biology of neuronal health and disease
- Developmental neuroscience
- Neuroimmunology
Faculty of Medicine
The Faculty of Medicine supports:
- Clinical research in neurodegenerative diseases
- Epidemiology and population studies
- Translational research
- Clinical trials for novel therapeutics
Institute of Neuroscience (Institut de Neurociències)
The Institute of Neuroscience coordinates interdisciplinary research across departments, focusing on:
- Alzheimer's disease pathogenesis and therapy
- Parkinson's disease and movement disorders
- Amyotrophic lateral sclerosis (ALS)
- Multiple sclerosis
- Neurodegeneration in aging
Key Research Areas
Alzheimer's Disease Research
UB researchers investigate:
- [Amyloid precursor protein](/entities/app-protein) (APP) processing and [amyloid-beta](/proteins/amyloid-beta) generation
- [Tau](/proteins/tau) protein pathology and spreading mechanisms
- Neuroinflammation and microglial activation
- Synaptic dysfunction in early AD
- Biomarker discovery for early diagnosis
- Genetic risk factors in Spanish populations
Parkinson's Disease Research
Research programs focus on:
- [Alpha-synuclein](/proteins/alpha-synuclein) aggregation and propagation
- Mitochondrial dysfunction in dopaminergic [neurons](/entities/neurons)
- Leucine-rich repeat kinase 2 (LRRK2) biology
- [GBA](/entities/gba) gene mutations in PD risk
- Deep brain stimulation outcomes
- Non-motor symptoms of PD
Neurodegeneration and Aging
The university studies:
- Cellular mechanisms of brain aging
- Mitochondrial dysfunction in neurodegeneration
- Oxidative stress and DNA damage responses
- Protein quality control systems ([autophagy](/entities/autophagy), ubiquitin-proteasome)
- Neurotrophic factor signaling
Notable Research Groups
Neurobiology of Aging Group
Led by Dr. Isidre Ferrer, this group studies the neurobiology of aging and neurodegenerative diseases, with particular focus on protein aggregation disorders and neuropathology of aging brains [2].
Neurodegeneration Research Unit
This unit investigates molecular mechanisms of neurodegeneration, including:
- Prion protein dynamics
- RNA binding proteins in ALS/FTD
- Mitochondrial quality control
- Calcium dysregulation in neuronal death
Clinical Collaboration
UB maintains close collaboration with:
- Hospital Clínic de Barcelona - Major teaching hospital
- Hospital de la Santa Creu i Sant Pau
- IDIBAPS (Biomedical Research Institute August Pi i Sunyer)
- Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED)
International Collaboration
UB participates in major European research initiatives:
- Joint Programme on Neurodegenerative Disease Research (JPND)
- European Alzheimer's Disease Initiative
- Horizon Europe research programs
- International Consortium on Alzheimer's Genetics
Training Programs
The university offers:
- Master's in Neuroscience
- PhD programs in Biomedical Sciences
- Clinical residency training in Neurology
- Postdoctoral research positions
- International student exchange programs
Alzheimer's Disease Research Program
The Universitat de Barcelona hosts a comprehensive Alzheimer's disease research program, investigating multiple aspects of disease pathogenesis and therapy. The work of Ferrer (2018) on the neuropathology of Alzheimer's disease has been instrumental in understanding the disease's progression[@ferrer2018], and UB researchers extend this knowledge through local population studies.
Amyloid and Tau Pathology
UB researchers investigate the fundamental mechanisms of amyloid-beta and tau protein accumulation in the brain:
- APP processing: Characterizing the enzymatic cleavage of [amyloid precursor protein](/entities/app-protein) (APP) that generates amyloid-beta peptides
- Amyloid aggregation: Studying the formation of toxic oligomers and plaques
- Tau phosphorylation: Investigating the kinases and phosphatases that regulate tau modification
- Tau spreading: Understanding how pathological tau propagates between neurons
Pascoal et al. (2020) demonstrated that amyloid and tau biomarkers provide complementary information for Alzheimer's disease diagnosis and tracking[@pascoal2020], enabling UB researchers to develop novel biomarker combinations for early detection.
Neuroinflammation
The university's research program emphasizes the critical role of neuroinflammation in Alzheimer's disease:
- Microglial activation: Characterizing the phenotypic changes in microglia during disease progression
- Inflammatory cytokines: Investigating how IL-1β, TNF-α, and other cytokines contribute to neuronal dysfunction
- Complement system: Studying the role of complement proteins in synaptic elimination
- Therapeutic targets: Identifying anti-inflammatory approaches that may modify disease progression
Neff et al. (2023) comprehensively reviewed neuroinflammation as a key driver of Alzheimer's disease pathogenesis[@neff2023], providing a framework for UB researchers investigating this critical mechanism.
Synaptic Dysfunction
Understanding the early synaptic changes that precede neuronal loss is a priority for UB researchers:
- Synaptic proteomics: Identifying the protein networks disrupted in early disease
- Electrophysiology: Characterizing changes in synaptic plasticity and transmission
- Structural analysis: Using electron microscopy to examine synaptic morphology
- Restore strategies: Testing interventions that may protect synaptic function
Selkoe's seminal work established that synaptic failure correlates with cognitive decline in Alzheimer's disease[@selkoe2019], and UB researchers build upon this foundation to identify protective strategies.
Parkinson's Disease Research Program
UB maintains a robust Parkinson's disease research program that addresses both motor and non-motor symptoms of the disease.
Alpha-Synuclein Biology
Research focuses on understanding the aggregation and propagation of [alpha-synuclein](/proteins/alpha-synuclein):
- Oligomer formation: Characterizing the toxic species that initiate cellular dysfunction
- Cell-to-cell transmission: Studying how pathological proteins spread through the brain
- Strain diversity: Investigating whether different alpha-synuclein strains produce distinct clinical phenotypes
- Clearance mechanisms: Enhancing cellular pathways that remove pathological proteins
Paz et al. (2020) provided a comprehensive review of new insights into Parkinson's disease pathogenesis[@paz2020], guiding UB researchers in identifying novel therapeutic targets.
Motor and Non-Motor Symptoms
Beyond the classical motor features, UB researchers investigate the diverse non-motor manifestations:
- Sleep disorders: REM sleep behavior disorder as a prodromal marker
- Olfactory dysfunction: Loss of smell as an early diagnostic feature
- Autonomic dysfunction: Gastrointestinal and cardiovascular manifestations
- Cognitive impairment: Dementia associated with advanced Parkinson's disease
Kalia and Lang (2015) systematically reviewed Parkinson's disease, providing the foundational framework for UB clinical research programs[@kalia2015].
Genetic Factors
The university investigates both sporadic and genetic forms of Parkinson's disease:
- LRRK2 biology: Understanding the most common genetic cause of Parkinson's disease
- GBA mutations: Characterizing how glucocerebrosidase variants increase risk
- Polygenic risk: Identifying the combined effect of multiple genetic variants
- Gene-environment interactions: Studying how genetic susceptibility interacts with environmental exposures
Neurodegeneration Mechanisms
UB researchers study the common mechanisms that underlie various neurodegenerative diseases:
Protein Quality Control
The university investigates cellular systems responsible for maintaining protein homeostasis:
- Autophagy: Characterizing lysosomal and macroautophagy pathways
- Ubiquitin-proteasome: Understanding the role of the proteasome in clearing misfolded proteins
- Chaperone systems: Investigating molecular chaperones that assist protein folding
- Aggresome formation: Studying how cells sequester toxic protein aggregates
Chartier and Duyckaerts (2024) recently proposed that Alzheimer's disease may fundamentally be a lysosomal disorder[@chartier2024], opening new therapeutic directions that UB researchers are exploring.
Mitochondrial Dysfunction
The role of impaired energy metabolism in neurodegeneration is a major research focus:
- Oxidative phosphorylation: Characterizing defects in the electron transport chain
- Calcium homeostasis: Understanding how mitochondrial calcium handling goes awry
- Apoptosis pathways: Investigating the triggers of programmed cell death
- Metabolic therapies: Testing approaches that may improve cellular energy production
Neurotrophic Factor Signaling
The university studies how growth factors that support neuronal survival are affected in neurodegeneration:
- BDNF signaling: Understanding how brain-derived neurotrophic factor supports synaptic function
- GDNF family: Investigating glial cell line-derived neurotrophic factor approaches
- Receptor biology: Characterizing the cell surface receptors that mediate neurotrophic effects
- Therapeutic delivery: Testing novel methods for delivering growth factors to the brain
Clinical Research Infrastructure
UB's clinical research capabilities enable translation of basic science discoveries:
Hospital Clínic de Barcelona Collaboration
The partnership with Hospital Clínic provides:
- Clinical trial infrastructure: Access to Phase I-III trials for new therapeutics
- Patient cohorts: Well-characterized populations for biomarker studies
- Neuroimaging: State-of-the-art MRI and PET facilities
- Neuropsychology: Comprehensive cognitive assessment capabilities
IDIBAPS Partnership
The Biomedical Research Institute August Pi i Sunyer (IDIBAPS) provides:
- Basic science laboratories: State-of-the-art facilities for molecular and cellular research
- Translational programs: Bridging basic discoveries to clinical applications
- Training opportunities: Fellowship programs for physician-scientists
- International networks: Connections to major research consortia worldwide
CIBERNED Integration
The university participates in the Biomedical Research Network for Neurodegenerative Diseases (CIBERNED), enabling:
- Multi-center studies: Collaborative projects across Spanish institutions
- Sample sharing: Access to biobanks of brain tissue and cerebrospinal fluid
- Clinical expertise: Sharing of specialized clinical knowledge
- Resource pooling: Combined resources for large-scale projects
Training and Education
UB provides comprehensive training in neurodegenerative disease research:
Graduate Programs
- Master's in Neuroscience: One-year program providing foundational knowledge
- PhD in Biomedical Sciences: Three-to-four year research training
- Clinical research training: Programs for medical doctors pursuing research careers
Postdoctoral Opportunities
- Basic science positions: Laboratory positions in neuroscience research
- Clinical research fellowships: Training in clinical trial design and execution
- International exchanges: Programs for training at partner institutions
Continuing Education
- Physician education: Courses for practicing neurologists and geriatricians
- Caregiver training: Programs for family members and professional caregivers
- Public awareness: Educational programs for the general public
International Collaboration
UB maintains active collaborations with leading institutions worldwide:
European Networks
- Joint Programme on Neurodegenerative Disease Research (JPND): European initiative for coordinated research
- European Alzheimer's Disease Consortium (EADC): Multi-center collaboration on clinical research
- Horizon Europe: Participation in funded European research projects
Global Partnerships
- Alzheimer's Association: Collaboration on international research initiatives
- Michael J. Fox Foundation: Partnership on Parkinson's disease research
- International Parkinson and Movement Disorders Society: Participation in global networks
Research Visits
The university hosts international scientists through:
- Visiting professor programs: Extended stays for collaborative research
- Conference hosting: Annual symposiums bringing together international experts
- Student exchanges: Programs for graduate students to train abroad
See Also
- [Institutions](/institutions) - All institution pages
- [Alzheimer's Disease](/diseases/alzheimers-disease) - Alzheimer's disease mechanisms
- [Parkinson's Disease](/diseases/parkinsons-disease) - Parkinson's disease mechanisms
External Links
- [Universitat de Barcelona](https://www.ub.edu/) - Official website
- [Faculty of Biology](https://www.ub.edu/biologia/)
- [Faculty of Medicine](https://www.ub.edu/medicina/)
- [Institute of Neuroscience](https://www.ub.edu/neurociencies/)
References
{#references}